Sanofi Ends Research Into 2 Experimental Zika Vaccines After U.S. Funding Focus Shifts
Wall Street Journal: Sanofi Stops Work on Two Zika Vaccines
“Drugmaker Sanofi SA has ended its development of two Zika virus vaccines, citing a decline in new infections and limits on U.S. government funding, in a move that illustrates the challenges in sustaining research in emerging infectious diseases after major outbreaks subside…” (Loftus, 9/6).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.